Send to

Choose Destination
Eur Respir J. 2018 Aug 16;52(2). pii: 1801025. doi: 10.1183/13993003.01025-2018. Print 2018 Aug.

Nonadherence with inhaled preventer therapy in severe asthmatic patients on long-term omalizumab.

Author information

Severe Asthma Service, Northwest Lung Centre, Wythenshawe Hospital, Manchester, UK.

Conflict of interest statement

Conflict of interest: D.J. Allen reports non-financial support from Mundipharma for attendance at the ERS meeting, and speaker fees for presenting at an educational meeting sponsored by Astra Zeneca, outside the submitted work. Conflict of interest: L-J. Holmes reports personal fees for speaking at conferences from Novartis and TEVA, outside the submitted work.

Publication type

Publication type

Supplemental Content

Full text links

Icon for HighWire
Loading ...
Support Center